No, not specific to breast cancer, according to the article :
"When she left in 2006, she took her research in a different direction, developing a way to test for A NUMBER OF CANCERS by examining SKIN and NAIL samples".
Either way, it obviously represents a threat to FER's investment.
Add to My Watchlist
What is My Watchlist?